Report Cover

Global Antimicrobial Peptides Market Insights and Forecast to 2027


Antimicrobial Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antimicrobial Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
    Plant Antimicrobial Peptides
    Microbial Antimicrobial Peptides
    Animal Antimicrobial Peptides

Segment by Application
    Pharmaceuticals
    Feed Additives
    Others

By Company
    AnaSpec
    AMP Biotech
    Phoenix Biotech
    Novabiotics
    Chinese Peptide
    Ontores
    GenScript
    Hycult Biotech
    Sunsmile
    Ruixing Biotechnology
    Zhongnong Yingtai Biotechnology
    Glam Technology
    ProteLight Pharmaceutical & Biotechnology

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Antimicrobial Peptides Product Introduction
    1.2 Market by Type
        1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type
        1.4.2 Plant Antimicrobial Peptides
        1.4.3 Microbial Antimicrobial Peptides
        1.2.4 Animal Antimicrobial Peptides
    1.3 Market by Application
        1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application
        1.3.2 Pharmaceuticals
        1.3.3 Feed Additives
        1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Antimicrobial Peptides Sales Estimates and Forecasts 2016-2027
    2.2 Global Antimicrobial Peptides Revenue Estimates and Forecasts 2016-2027
    2.3 Global Antimicrobial Peptides Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Antimicrobial Peptides Regions by Sales
        2.4.1 Global Top Antimicrobial Peptides Regions by Sales (2016-2021)
        2.4.2 Global Top Antimicrobial Peptides Regions by Sales (2022-2027)
    2.5 Global Top Antimicrobial Peptides Regions by Revenue
        2.5.1 Global Top Antimicrobial Peptides Regions by Revenue (2016-2021)
        2.5.2 Global Top Antimicrobial Peptides Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Antimicrobial Peptides Sales by Manufacturers
        3.1.1 Global Top Antimicrobial Peptides Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Sales in 2020
    3.2 Global Antimicrobial Peptides Revenue by Manufacturers
        3.2.1 Global Top Antimicrobial Peptides Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Revenue in 2020
    3.3 Global Antimicrobial Peptides Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Antimicrobial Peptides Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Antimicrobial Peptides Sales by Type
        4.1.1 Global Antimicrobial Peptides Historical Sales by Type (2016-2021)
        4.1.2 Global Antimicrobial Peptides Forecasted Sales by Type (2022-2027)
        4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    4.2 Global Antimicrobial Peptides Revenue by Type
        4.2.1 Global Antimicrobial Peptides Historical Revenue by Type (2016-2021)
        4.2.2 Global Antimicrobial Peptides Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    4.3 Global Antimicrobial Peptides Price by Type
        4.3.1 Global Antimicrobial Peptides Price by Type (2016-2021)
        4.3.2 Global Antimicrobial Peptides Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Antimicrobial Peptides Sales by Application
        5.1.1 Global Antimicrobial Peptides Historical Sales by Application (2016-2021)
        5.1.2 Global Antimicrobial Peptides Forecasted Sales by Application (2022-2027)
        5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    5.2 Global Antimicrobial Peptides Revenue by Application
        5.2.1 Global Antimicrobial Peptides Historical Revenue by Application (2016-2021)
        5.2.2 Global Antimicrobial Peptides Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    5.3 Global Antimicrobial Peptides Price by Application
        5.3.1 Global Antimicrobial Peptides Price by Application (2016-2021)
        5.3.2 Global Antimicrobial Peptides Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Antimicrobial Peptides Market Size by Type
        6.1.1 North America Antimicrobial Peptides Sales by Type (2016-2027)
        6.1.2 North America Antimicrobial Peptides Revenue by Type (2016-2027)
    6.2 North America Antimicrobial Peptides Market Size by Application
        6.2.1 North America Antimicrobial Peptides Sales by Application (2016-2027)
        6.2.2 North America Antimicrobial Peptides Revenue by Application (2016-2027)
    6.3 North America Antimicrobial Peptides Market Size by Country
        6.3.1 North America Antimicrobial Peptides Sales by Country (2016-2027)
        6.3.2 North America Antimicrobial Peptides Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Antimicrobial Peptides Market Size by Type
        7.1.1 Europe Antimicrobial Peptides Sales by Type (2017-2027)
        7.1.2 Europe Antimicrobial Peptides Revenue by Type (2017-2027)
    7.2 Europe Antimicrobial Peptides Market Size by Application
        7.2.1 Europe Antimicrobial Peptides Sales by Application (2017-2027)
        7.2.2 Europe Antimicrobial Peptides Revenue by Application (2017-2027)
    7.3 Europe Antimicrobial Peptides Market Size by Country
        7.3.1 Europe Antimicrobial Peptides Sales by Country (2017-2027)
        7.3.2 Europe Antimicrobial Peptides Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Antimicrobial Peptides Market Size by Type
        8.1.1 Asia Pacific Antimicrobial Peptides Sales by Type (2018-2027)
        8.1.2 Asia Pacific Antimicrobial Peptides Revenue by Type (2018-2027)
    8.2 Asia Pacific Antimicrobial Peptides Market Size by Application
        8.2.1 Asia Pacific Antimicrobial Peptides Sales by Application (2018-2027)
        8.2.2 Asia Pacific Antimicrobial Peptides Revenue by Application (2018-2027)
    8.3 Asia Pacific Antimicrobial Peptides Market Size by Region
        8.3.1 Asia Pacific Antimicrobial Peptides Sales by Region (2018-2027)
        8.3.2 Asia Pacific Antimicrobial Peptides Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Antimicrobial Peptides Market Size by Type
        9.1.1 Latin America Antimicrobial Peptides Sales by Type (2019-2027)
        9.1.2 Latin America Antimicrobial Peptides Revenue by Type (2019-2027)
    9.2 Latin America Antimicrobial Peptides Market Size by Application
        9.2.1 Latin America Antimicrobial Peptides Sales by Application (2019-2027)
        9.2.2 Latin America Antimicrobial Peptides Revenue by Application (2019-2027)
    9.3 Latin America Antimicrobial Peptides Market Size by Country
        9.3.1 Latin America Antimicrobial Peptides Sales by Country (2019-2027)
        9.3.2 Latin America Antimicrobial Peptides Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Antimicrobial Peptides Market Size by Type
        6.1.1 Middle East and Africa Antimicrobial Peptides Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Antimicrobial Peptides Revenue by Type (2016-2027)
    6.2 Middle East and Africa Antimicrobial Peptides Market Size by Application
        6.2.1 Middle East and Africa Antimicrobial Peptides Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Application (2016-2027)
    6.3 Middle East and Africa Antimicrobial Peptides Market Size by Country
        6.3.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 AnaSpec
        11.1.1 AnaSpec Corporation Information
        11.1.2 AnaSpec Overview
        11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 AnaSpec Antimicrobial Peptides Product Description
        11.1.5 AnaSpec Related Developments
    11.2 AMP Biotech
        11.2.1 AMP Biotech Corporation Information
        11.2.2 AMP Biotech Overview
        11.2.3 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 AMP Biotech Antimicrobial Peptides Product Description
        11.2.5 AMP Biotech Related Developments
    11.3 Phoenix Biotech
        11.3.1 Phoenix Biotech Corporation Information
        11.3.2 Phoenix Biotech Overview
        11.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Phoenix Biotech Antimicrobial Peptides Product Description
        11.3.5 Phoenix Biotech Related Developments
    11.4 Novabiotics
        11.4.1 Novabiotics Corporation Information
        11.4.2 Novabiotics Overview
        11.4.3 Novabiotics Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Novabiotics Antimicrobial Peptides Product Description
        11.4.5 Novabiotics Related Developments
    11.5 Chinese Peptide
        11.5.1 Chinese Peptide Corporation Information
        11.5.2 Chinese Peptide Overview
        11.5.3 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Chinese Peptide Antimicrobial Peptides Product Description
        11.5.5 Chinese Peptide Related Developments
    11.6 Ontores
        11.6.1 Ontores Corporation Information
        11.6.2 Ontores Overview
        11.6.3 Ontores Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Ontores Antimicrobial Peptides Product Description
        11.6.5 Ontores Related Developments
    11.7 GenScript
        11.7.1 GenScript Corporation Information
        11.7.2 GenScript Overview
        11.7.3 GenScript Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 GenScript Antimicrobial Peptides Product Description
        11.7.5 GenScript Related Developments
    11.8 Hycult Biotech
        11.8.1 Hycult Biotech Corporation Information
        11.8.2 Hycult Biotech Overview
        11.8.3 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Hycult Biotech Antimicrobial Peptides Product Description
        11.8.5 Hycult Biotech Related Developments
    11.9 Sunsmile
        11.9.1 Sunsmile Corporation Information
        11.9.2 Sunsmile Overview
        11.9.3 Sunsmile Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Sunsmile Antimicrobial Peptides Product Description
        11.9.5 Sunsmile Related Developments
    11.10 Ruixing Biotechnology
        11.10.1 Ruixing Biotechnology Corporation Information
        11.10.2 Ruixing Biotechnology Overview
        11.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Description
        11.10.5 Ruixing Biotechnology Related Developments
    11.1 AnaSpec
        11.1.1 AnaSpec Corporation Information
        11.1.2 AnaSpec Overview
        11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 AnaSpec Antimicrobial Peptides Product Description
        11.1.5 AnaSpec Related Developments
    11.12 Glam Technology
        11.12.1 Glam Technology Corporation Information
        11.12.2 Glam Technology Overview
        11.12.3 Glam Technology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Glam Technology Product Description
        11.12.5 Glam Technology Related Developments
    11.13 ProteLight Pharmaceutical & Biotechnology
        11.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
        11.13.2 ProteLight Pharmaceutical & Biotechnology Overview
        11.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 ProteLight Pharmaceutical & Biotechnology Product Description
        11.13.5 ProteLight Pharmaceutical & Biotechnology Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Antimicrobial Peptides Value Chain Analysis
    12.2 Antimicrobial Peptides Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Antimicrobial Peptides Production Mode & Process
    12.4 Antimicrobial Peptides Sales and Marketing
        12.4.1 Antimicrobial Peptides Sales Channels
        12.4.2 Antimicrobial Peptides Distributors
    12.5 Antimicrobial Peptides Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Antimicrobial Peptides Industry Trends
    13.2 Antimicrobial Peptides Market Drivers
    13.3 Antimicrobial Peptides Market Challenges
    13.4 Antimicrobial Peptides Market Restraints

14 Key Findings in The Global Antimicrobial Peptides Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Plant Antimicrobial Peptides Table 3. Major Manufacturers of Microbial Antimicrobial Peptides Table 4. Major Manufacturers of Animal Antimicrobial Peptides Table 5. Global Antimicrobial Peptides Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Antimicrobial Peptides Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Antimicrobial Peptides Sales by Region (2016-2021) & (Mg) Table 8. Global Antimicrobial Peptides Sales Market Share by Region (2016-2021) Table 9. Global Antimicrobial Peptides Sales by Region (2016-2021) & (Mg) Table 10. Global Antimicrobial Peptides Sales Market Share by Region (2022-2027) Table 11. Global Antimicrobial Peptides Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Antimicrobial Peptides Revenue Market Share by Region (2016-2021) Table 13. Global Antimicrobial Peptides Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Antimicrobial Peptides Revenue Market Share by Region (2022-2027) Table 15. Global Antimicrobial Peptides Sales by Manufacturers (2016-2021) & (Mg) Table 16. Global Antimicrobial Peptides Sales Share by Manufacturers (2016-2021) Table 17. Global Antimicrobial Peptides Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Antimicrobial Peptides Revenue Share by Manufacturers (2016-2021) Table 19. Antimicrobial Peptides Price by Manufacturers 2016-2021 (US$/Mg) Table 20. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2020) Table 22. Antimicrobial Peptides Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Antimicrobial Peptides Product Offered Table 24. Date of Manufacturers Enter into Antimicrobial Peptides Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Antimicrobial Peptides Sales by Type (2016-2021) & (Mg) Table 27. Global Antimicrobial Peptides Sales by Type (2022-2027) & (Mg) Table 28. Global Antimicrobial Peptides Sales Share by Type (2016-2021) Table 29. Global Antimicrobial Peptides Sales Share by Type (2022-2027) Table 30. Global Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Antimicrobial Peptides Revenue Share by Type (2016-2021) Table 33. Global Antimicrobial Peptides Revenue Share by Type (2022-2027) Table 34. Antimicrobial Peptides Price by Type (2016-2021) & (US$/Mg) Table 35. Global Antimicrobial Peptides Price Forecast by Type (2022-2027) & (US$/Mg) Table 36. Global Antimicrobial Peptides Sales by Application (2016-2021) & (Mg) Table 37. Global Antimicrobial Peptides Sales by Application (2022-2027) & (Mg) Table 38. Global Antimicrobial Peptides Sales Share by Application (2016-2021) Table 39. Global Antimicrobial Peptides Sales Share by Application (2022-2027) Table 40. Global Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Antimicrobial Peptides Revenue Share by Application (2016-2021) Table 43. Global Antimicrobial Peptides Revenue Share by Application (2022-2027) Table 44. Antimicrobial Peptides Price by Application (2016-2021) & (US$/Mg) Table 45. Global Antimicrobial Peptides Price Forecast by Application (2022-2027) & (US$/Mg) Table 46. North America Antimicrobial Peptides Sales by Type (2016-2021) & (Mg) Table 47. North America Antimicrobial Peptides Sales by Type (2022-2027) & (Mg) Table 48. North America Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Antimicrobial Peptides Sales by Application (2016-2021) & (Mg) Table 51. North America Antimicrobial Peptides Sales by Application (2022-2027) & (Mg) Table 52. North America Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Antimicrobial Peptides Sales by Country (2016-2021) & (Mg) Table 55. North America Antimicrobial Peptides Sales by Country (2022-2027) & (Mg) Table 56. North America Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Antimicrobial Peptides Sales by Type (2016-2021) & (Mg) Table 59. Europe Antimicrobial Peptides Sales by Type (2022-2027) & (Mg) Table 60. Europe Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Antimicrobial Peptides Sales by Application (2016-2021) & (Mg) Table 63. Europe Antimicrobial Peptides Sales by Application (2022-2027) & (Mg) Table 64. Europe Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Antimicrobial Peptides Sales by Country (2016-2021) & (Mg) Table 67. Europe Antimicrobial Peptides Sales by Country (2022-2027) & (Mg) Table 68. Europe Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Antimicrobial Peptides Sales by Type (2016-2021) & (Mg) Table 71. Asia Pacific Antimicrobial Peptides Sales by Type (2022-2027) & (Mg) Table 72. Asia Pacific Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Antimicrobial Peptides Sales by Application (2016-2021) & (Mg) Table 75. Asia Pacific Antimicrobial Peptides Sales by Application (2022-2027) & (Mg) Table 76. Asia Pacific Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Antimicrobial Peptides Sales by Region (2016-2021) & (Mg) Table 79. Asia Pacific Antimicrobial Peptides Sales by Region (2022-2027) & (Mg) Table 80. Asia Pacific Antimicrobial Peptides Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Antimicrobial Peptides Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Antimicrobial Peptides Sales by Type (2016-2021) & (Mg) Table 83. Latin America Antimicrobial Peptides Sales by Type (2022-2027) & (Mg) Table 84. Latin America Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Antimicrobial Peptides Sales by Application (2016-2021) & (Mg) Table 87. Latin America Antimicrobial Peptides Sales by Application (2022-2027) & (Mg) Table 88. Latin America Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Antimicrobial Peptides Sales by Country (2016-2021) & (Mg) Table 91. Latin America Antimicrobial Peptides Sales by Country (2022-2027) & (Mg) Table 92. Latin America Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Antimicrobial Peptides Sales by Type (2016-2021) & (Mg) Table 95. Middle East and Africa Antimicrobial Peptides Sales by Type (2022-2027) & (Mg) Table 96. Middle East and Africa Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Antimicrobial Peptides Sales by Application (2016-2021) & (Mg) Table 99. Middle East and Africa Antimicrobial Peptides Sales by Application (2022-2027) & (Mg) Table 100. Middle East and Africa Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Antimicrobial Peptides Sales by Country (2016-2021) & (Mg) Table 103. Middle East and Africa Antimicrobial Peptides Sales by Country (2022-2027) & (Mg) Table 104. Middle East and Africa Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million) Table 106. AnaSpec Corporation Information Table 107. AnaSpec Description and Major Businesses Table 108. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 109. AnaSpec Antimicrobial Peptides Product Table 110. AnaSpec Recent Developments Table 111. AMP Biotech Corporation Information Table 112. AMP Biotech Description and Major Businesses Table 113. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 114. AMP Biotech Antimicrobial Peptides Product Table 115. AMP Biotech Recent Developments Table 116. Phoenix Biotech Corporation Information Table 117. Phoenix Biotech Description and Major Businesses Table 118. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 119. Phoenix Biotech Antimicrobial Peptides Product Table 120. Phoenix Biotech Recent Developments Table 121. Novabiotics Corporation Information Table 122. Novabiotics Description and Major Businesses Table 123. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 124. Novabiotics Antimicrobial Peptides Product Table 125. Novabiotics Recent Developments Table 126. Chinese Peptide Corporation Information Table 127. Chinese Peptide Description and Major Businesses Table 128. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 129. Chinese Peptide Antimicrobial Peptides Product Table 130. Chinese Peptide Recent Developments Table 131. Ontores Corporation Information Table 132. Ontores Description and Major Businesses Table 133. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 134. Ontores Antimicrobial Peptides Product Table 135. Ontores Recent Developments Table 136. GenScript Corporation Information Table 137. GenScript Description and Major Businesses Table 138. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 139. GenScript Antimicrobial Peptides Product Table 140. GenScript Recent Developments Table 141. Hycult Biotech Corporation Information Table 142. Hycult Biotech Description and Major Businesses Table 143. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 144. Hycult Biotech Antimicrobial Peptides Product Table 145. Hycult Biotech Recent Developments Table 146. Sunsmile Corporation Information Table 147. Sunsmile Description and Major Businesses Table 148. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 149. Sunsmile Antimicrobial Peptides Product Table 150. Sunsmile Recent Developments Table 151. Ruixing Biotechnology Corporation Information Table 152. Ruixing Biotechnology Description and Major Businesses Table 153. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 154. Ruixing Biotechnology Antimicrobial Peptides Product Table 155. Ruixing Biotechnology Recent Developments Table 156. Zhongnong Yingtai Biotechnology Corporation Information Table 157. Zhongnong Yingtai Biotechnology Description and Major Businesses Table 158. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 159. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Table 160. Zhongnong Yingtai Biotechnology Recent Developments Table 161. Glam Technology Corporation Information Table 162. Glam Technology Description and Major Businesses Table 163. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 164. Glam Technology Antimicrobial Peptides Product Table 165. Glam Technology Recent Developments Table 166. ProteLight Pharmaceutical & Biotechnology Corporation Information Table 167. ProteLight Pharmaceutical & Biotechnology Description and Major Businesses Table 168. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021) Table 169. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Table 170. ProteLight Pharmaceutical & Biotechnology Recent Developments Table 171. Key Raw Materials Lists Table 172. Raw Materials Key Suppliers Lists Table 173. Antimicrobial Peptides Distributors List Table 174. Antimicrobial Peptides Customers List Table 175. Antimicrobial Peptides Market Trends Table 176. Antimicrobial Peptides Market Drivers Table 177. Antimicrobial Peptides Market Challenges Table 178. Antimicrobial Peptides Market Restraints Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Antimicrobial Peptides Product Picture Figure 2. Global Antimicrobial Peptides Market Share by Type in 2020 & 2027 Figure 3. Plant Antimicrobial Peptides Product Picture Figure 4. Microbial Antimicrobial Peptides Product Picture Figure 5. Animal Antimicrobial Peptides Product Picture Figure 6. Global Antimicrobial Peptides Sales Market Share by Application in 2020 & 2027 Figure 7. Pharmaceuticals Figure 8. Feed Additives Figure 9. Others Figure 10. Antimicrobial Peptides Report Years Considered Figure 11. Global Antimicrobial Peptides Sales 2016-2027 (Mg) Figure 12. Global Antimicrobial Peptides Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Antimicrobial Peptides Revenue 2016-2027 (US$ Million) Figure 14. Global Antimicrobial Peptides Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 15. Global Antimicrobial Peptides Sales Market Share by Region (2016-2021) Figure 16. Global Antimicrobial Peptides Sales Market Share by Region (2022-2027) Figure 17. North America Antimicrobial Peptides Sales YoY (2016-2027) & (Mg) Figure 18. North America Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million) Figure 19. Europe Antimicrobial Peptides Sales YoY (2016-2027) & (Mg) Figure 20. Europe Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million) Figure 21. Asia-Pacific Antimicrobial Peptides Sales YoY (2016-2027) & (Mg) Figure 22. Asia-Pacific Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million) Figure 23. Latin America Antimicrobial Peptides Sales YoY (2016-2027) & (Mg) Figure 24. Latin America Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million) Figure 25. Middle East & Africa Antimicrobial Peptides Sales YoY (2016-2027) & (Mg) Figure 26. Middle East & Africa Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million) Figure 27. The Top 10 and Top 5 Players Market Share by Antimicrobial Peptides Sales in 2020 Figure 28. The Top 10 and Top 5 Players Market Share by Antimicrobial Peptides Revenue in 2020 Figure 29. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 30. Global Antimicrobial Peptides Sales Market Share by Type (2016-2027) Figure 31. Global Antimicrobial Peptides Revenue Market Share by Type (2016-2027) Figure 32. Global Antimicrobial Peptides Sales Market Share by Application (2016-2027) Figure 33. Global Antimicrobial Peptides Revenue Market Share by Application (2016-2027) Figure 34. North America Antimicrobial Peptides Sales Market Share by Type (2016-2027) Figure 35. North America Antimicrobial Peptides Revenue Market Share by Type (2016-2027) Figure 36. North America Antimicrobial Peptides Sales Market Share by Application (2016-2027) Figure 37. North America Antimicrobial Peptides Revenue Market Share by Application (2016-2027) Figure 38. North America Antimicrobial Peptides Sales Share by Country (2016-2027) Figure 39. North America Antimicrobial Peptides Revenue Share by Country (2016-2027) Figure 40. U.S. Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 41. Canada Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 42. Europe Antimicrobial Peptides Sales Market Share by Type (2016-2027) Figure 43. Europe Antimicrobial Peptides Revenue Market Share by Type (2016-2027) Figure 44. Europe Antimicrobial Peptides Sales Market Share by Application (2016-2027) Figure 45. Europe Antimicrobial Peptides Revenue Market Share by Application (2016-2027) Figure 46. Europe Antimicrobial Peptides Sales Share by Country (2016-2027) Figure 47. Europe Antimicrobial Peptides Revenue Share by Country (2016-2027) Figure 48. Germany Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 49. France Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 50. U.K. Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 51. Italy Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 52. Russia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 53. Asia Pacific Antimicrobial Peptides Sales Market Share by Type (2016-2027) Figure 54. Asia Pacific Antimicrobial Peptides Revenue Market Share by Type (2016-2027) Figure 55. Asia Pacific Antimicrobial Peptides Sales Market Share by Application (2016-2027) Figure 56. Asia Pacific Antimicrobial Peptides Revenue Market Share by Application (2016-2027) Figure 57. Asia Pacific Antimicrobial Peptides Sales Share by Region (2016-2027) Figure 58. Asia Pacific Antimicrobial Peptides Revenue Share by Region (2016-2027) Figure 59. China Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 60. Japan Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 61. South Korea Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 62. India Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 63. Australia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 64. Taiwan Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 65. Indonesia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 66. Thailand Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 67. Malaysia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 68. Philippines Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 69. Latin America Antimicrobial Peptides Sales Market Share by Type (2016-2027) Figure 70. Latin America Antimicrobial Peptides Revenue Market Share by Type (2016-2027) Figure 71. Latin America Antimicrobial Peptides Sales Market Share by Application (2016-2027) Figure 72. Latin America Antimicrobial Peptides Revenue Market Share by Application (2016-2027) Figure 73. Latin America Antimicrobial Peptides Sales Share by Country (2016-2027) Figure 74. Latin America Antimicrobial Peptides Revenue Share by Country (2016-2027) Figure 75. Mexico Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 76. Brazil Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 77. Argentina Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 78. Middle East and Africa Antimicrobial Peptides Sales Market Share by Type (2016-2027) Figure 79. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Type (2016-2027) Figure 80. Middle East and Africa Antimicrobial Peptides Sales Market Share by Application (2016-2027) Figure 81. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Application (2016-2027) Figure 82. Middle East and Africa Antimicrobial Peptides Sales Share by Country (2016-2027) Figure 83. Middle East and Africa Antimicrobial Peptides Revenue Share by Country (2016-2027) Figure 84. Turkey Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 85. Saudi Arabia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 86. U.A.E Antimicrobial Peptides Revenue (2016-2027) & (US$ Million) Figure 87. Antimicrobial Peptides Value Chain Figure 88. Antimicrobial Peptides Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us